The expanding role of the HMG-CoA reductase inhibitor, the most widely prescribed drug in the world
Futterman, L.G.; Lemberg, L.
American Journal of Critical Care An Official Publication American Association of Critical-Care Nurses 14(6): 555-558
2005
ISSN/ISBN: 1062-3264 PMID: 16249593 Document Number: 587632
Document emailed within 1 workday
Related Documents
Giannoukakis, N. 2006: Drug evaluation: ranirestat--an aldose reductase inhibitor for the potential treatment of diabetic complications Current Opinion in Investigational Drugs 7(10): 916-923Kotyla, P.J.; Sliwinska-Kotyla, B.; Kucharz, E.J. 2006: Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin Journal of rheumatology 33(11): 2361-3; author reply 2363
Isley, W.L.. 2001: Pitavastatin (NK-104), a new HMG-CoA reductase inhibitor Drugs of Today 37(9): 587-594
Bousquet, P.; Gayet, J-Louis. 2003: Pharmacologic characteristics of rosuvastatin, a new HMG-CoA reductase inhibitor Therapie 58(2): 113-121
Kador, P.F.; Sharpless, N.E. 1983: Pharmacophor requirements of the aldose reductase inhibitor site Molecular Pharmacology 24(3): 521-531
Neimark, A.I.; Davydov, A.V.; Aliev, R.T. 2018: The effects of combination therapy with 5-reductase inhibitor and -blocker on the prognosis of BPH Urologiia 2: 62-66
Gervasi, G.B.; Bartoli, C.; Catalani, R.; Farina, C.; Carpita, G.; Caccia, G.; Ammannati, P. 1991: Effects of a new aldose reductase inhibitor on diabetic complications in rats Arzneimittel-Forschung 41(11): 1160-1163
Frye, S.V.; Bramson, H.N.; Hermann, D.J.; Lee, F.W.; Sinhababu, A.K.; Tian, G. 1998: Discovery and development of GG745, a potent inhibitor of both isozymes of 5 alpha-reductase Pharmaceutical Biotechnology 11: 393-422
Cabeza, M.; Bratoeff, E.; Heuze, I.; Ramírez, E.; Sánchez, M.; Flores, E. 2003: Effect of beta-sitosterol as inhibitor of 5 alpha-reductase in hamster prostate Proceedings of the Western Pharmacology Society 46: 153-155
Giannini, S.D.; de Góes, J.M.; Dereviack, B.E.; Machado, C.; Forti, N.; Diament, J. 1990: Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis Arquivos Brasileiros de Cardiologia 54(6): 407-414
Kojima, K.; Matsubara, H.; Harada, T.; Mizuno, K.; Suzuki, M.; Hotta, N.; Kakuta, H.; Sakamoto, N. 1985: Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats Japanese Journal of Ophthalmology 29(1): 99-109
Terranova, R.; Luca, S. 1993: Treatment with an aldose reductase inhibitor in peripheral neuropathy in elderly diabetic patients Minerva Medica 84(9): 461-466
Seale, L.R.; Eglini, A.N.; McMichael, A.J. 2016: Side Effects Related to 5 α-Reductase Inhibitor Treatment of Hair Loss in Women: a Review Journal of Drugs in Dermatology: Jdd 15(4): 414-419
Schwartz, G.E.; Russek, L.G.; Shapiro, L.; Harada, P. 1999: Loving openness as a meta-world hypothesis: expanding our vision of mind and medicine Advances in Mind-Body Medicine 15(1): 5-19
Persson, C.; Kardell, M.; Karanti, A.; Isgren, A.; Annerbrink, K.; Landen, M. 2017: Prescribed drug use for bipolar disorder type i and Ii in clinical practice Lakartidningen 114
Peppard, W.J.; Schuenke, C.D. 2008: Iclaprim, a diaminopyrimidine dihydrofolate reductase inhibitor for the potential treatment of antibiotic-resistant staphylococcal infections Current Opinion in Investigational Drugs 9(2): 210-225
Terubayashi, H.; Akagi, Y. 1989: The effect of aldose reductase inhibitor, statil, on hyperpermeability of iridial vessels in experimental galactosemic rats Japanese Journal of Ophthalmology 33(3): 343-347
Matzkin, H.; Chayen, R.; Goldfarb, H.; Gilad, S.; Braf, Z. 1992: Laboratory monitoring of androgenic activity in benign prostate hypertrophy treated with a 5 alpha-reductase inhibitor Clinical Chemistry 38(7): 1304-1306
Kofo-Abayomi, A.; Lucas, P.D. 1987: Muscarinic receptor density is reduced in diabetic rat atria, an effect prevented by the aldose reductase inhibitor, Statil Journal of Pharmacy and Pharmacology 39(12): 1019-1021
Truter, I.; Kotze, T.J. 1996: A drug utilisation study investigating prescribed daily doses of hypolipidaemic agents South African Medical Journal 86(11): 1397-1401